Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid Beta and impairment of learning and memory - PubMed (original) (raw)
. 2006 Apr;317(1):334-40.
doi: 10.1124/jpet.105.095687. Epub 2005 Dec 28.
Affiliations
- PMID: 16382024
- DOI: 10.1124/jpet.105.095687
Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid Beta and impairment of learning and memory
Li-Bo Zou et al. J Pharmacol Exp Ther. 2006 Apr.
Abstract
An imbalance between anabolism and catabolism causes an accumulation of amyloid beta-peptide (Abeta), which is a proposed trigger of the onset of Alzheimer's disease. Neprilysin is a rate-limiting peptidase that participates in the catabolism of Abeta in the brain. We examined whether rats continuously infused with thiorphan, a specific neprilysin inhibitor, into the hippocampus develop cognitive impairments through accumulation of Abeta. Thiorphan infusion elevated hippocampal Abeta40 and Abeta42 levels in the insoluble but not the soluble fraction. Thiorphan-infused rats displayed cognitive impairments in the ability to discriminate in the object recognition test, associative learning in the conditioned fear learning test, and spatial memory in the water maze test, tasks that depend on the hippocampus. These cognitive abilities in the battery of behavioral tasks inversely correlated with insoluble Abeta contents in the hippocampus. The nicotine-stimulated release of acetylcholine in the hippocampus of thiorphan-infused rats was significantly lower than that in vehicle-infused rats. These results indicate that continuous infusion of thiorphan into the hippocampus causes cognitive dysfunction and reduces cholinergic activity by raising the level of Abeta in the hippocampus and suggest that a reduction of neprilysin activity contributes to the deposition of Abeta and development of Alzheimer's disease.
Similar articles
- Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid beta and impairment of learning and memory.
Mouri A, Zou LB, Iwata N, Saido TC, Wang D, Wang MW, Noda Y, Nabeshima T. Mouri A, et al. Behav Brain Res. 2006 Mar 15;168(1):83-91. doi: 10.1016/j.bbr.2005.10.014. Epub 2005 Dec 19. Behav Brain Res. 2006. PMID: 16360221 - Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat.
Yamaguchi Y, Miyashita H, Tsunekawa H, Mouri A, Kim HC, Saito K, Matsuno T, Kawashima S, Nabeshima T. Yamaguchi Y, et al. J Pharmacol Exp Ther. 2006 Jun;317(3):1079-87. doi: 10.1124/jpet.105.098640. Epub 2006 Feb 10. J Pharmacol Exp Ther. 2006. PMID: 16474004 - Metabolism of amyloid-beta peptide and Alzheimer's disease.
Iwata N, Higuchi M, Saido TC. Iwata N, et al. Pharmacol Ther. 2005 Nov;108(2):129-48. doi: 10.1016/j.pharmthera.2005.03.010. Epub 2005 Aug 19. Pharmacol Ther. 2005. PMID: 16112736 Review. - Role of Prenatal Hypoxia in Brain Development, Cognitive Functions, and Neurodegeneration.
Nalivaeva NN, Turner AJ, Zhuravin IA. Nalivaeva NN, et al. Front Neurosci. 2018 Nov 19;12:825. doi: 10.3389/fnins.2018.00825. eCollection 2018. Front Neurosci. 2018. PMID: 30510498 Free PMC article. Review.
Cited by
- The Amyloid-β Pathway in Alzheimer's Disease.
Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL, Cho M, Lannfelt L, Cummings JL, Vergallo A. Hampel H, et al. Mol Psychiatry. 2021 Oct;26(10):5481-5503. doi: 10.1038/s41380-021-01249-0. Epub 2021 Aug 30. Mol Psychiatry. 2021. PMID: 34456336 Free PMC article. Review. - Brain Shuttle Neprilysin reduces central Amyloid-β levels.
Campos CR, Kemble AM, Niewoehner J, Freskgård PO, Urich E. Campos CR, et al. PLoS One. 2020 Mar 10;15(3):e0229850. doi: 10.1371/journal.pone.0229850. eCollection 2020. PLoS One. 2020. PMID: 32155191 Free PMC article. - Association of MME gene polymorphisms with susceptibility to Alzheimer's disease in an Iranian population.
Khalili-Moghadam F, Hosseini Nejad J, Badri T, Sadeghi M, Gharechahi J. Khalili-Moghadam F, et al. Heliyon. 2024 Sep 6;10(18):e37556. doi: 10.1016/j.heliyon.2024.e37556. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39309779 Free PMC article. - Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease.
El-Amouri SS, Zhu H, Yu J, Marr R, Verma IM, Kindy MS. El-Amouri SS, et al. Am J Pathol. 2008 May;172(5):1342-54. doi: 10.2353/ajpath.2008.070620. Epub 2008 Apr 10. Am J Pathol. 2008. PMID: 18403590 Free PMC article. - Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer's disease.
Kaur D, Sharma V, Deshmukh R. Kaur D, et al. Inflammopharmacology. 2019 Aug;27(4):663-677. doi: 10.1007/s10787-019-00580-x. Epub 2019 Mar 14. Inflammopharmacology. 2019. PMID: 30874945 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical